Related Experiment Videos
Elevated maternal alpha-fetoprotein levels with subsequent fetal exsanguination
American Journal of Obstetrics and Gynecology
|May 1, 1985
Summary
Persistently high maternal serum alpha-fetoprotein, despite normal amniotic fluid levels, may indicate fetal-maternal bleeding. This condition poses risks, including fetal death and rhesus sensitization.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Clinical Biochemistry
Background:
- Elevated maternal serum alpha-fetoprotein (MSAFP) is a screening marker used in prenatal diagnosis.
- Normal amniotic fluid alpha-fetoprotein (AFAFP) levels typically suggest the absence of major fetal abnormalities.
- Fetal-maternal hemorrhage is a known complication in pregnancy.
Observation:
- A case presented with persistently elevated MSAFP levels.
- Amniotic fluid alpha-fetoprotein levels were consistently normal in this case.
- The pregnancy was complicated by significant fetal-maternal bleeding.
- The fetus ultimately died.
Findings:
- Persistent elevation of MSAFP with normal AFAFP can be indicative of fetal-maternal bleeding.
- Fetal-maternal bleeding can lead to adverse fetal outcomes, including fetal demise.
- Rhesus sensitization is a potential risk associated with fetal-maternal transfusion.
Implications:
- Clinicians should consider fetal-maternal bleeding in cases of unexplained elevated MSAFP, even with normal AFAFP.
- Early detection and management of fetal-maternal bleeding are crucial for improving fetal outcomes.
- This case highlights the importance of a comprehensive evaluation when interpreting MSAFP screening results.